Workflow
OrthoPediatrics(KIDS)
icon
Search documents
OrthoPediatrics(KIDS) - 2020 Q3 - Quarterly Report
2020-11-05 21:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR (State or other jurisdic ...
OrthoPediatrics(KIDS) - 2020 Q2 - Earnings Call Presentation
2020-08-10 16:43
| --- | --- | --- | |------------------------------------|-------|-----------------------------------------------------------------| | | | | | | | | | OrthoPediatrics Corp. August 2020 | | Mark Throdahl, CEO Fred Hite, COO & CFO Dave Bailey, President | | | | | | | | | Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of U.S. federal securities laws. You can identify forward-looking statements by the use of words such as "may," "might," "will," ...
OrthoPediatrics(KIDS) - 2020 Q2 - Earnings Call Transcript
2020-08-08 22:19
OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Emma Poalillo - Investor Relations Mark Throdahl - Chief Executive Officer Fred Hite - Chief Operating Officer and Chief Financial Officer David Bailey - President Conference Call Participants Patrick Allen - Piper Sandler Ryan Zimmerman - BTIG Kaila Krum - Truist Securities Mike Matson - Needham and Company Dave Turkaly - JMP Securities Operator Welcome to the Q2 2020 OrthoPediatrics Corp Ear ...
OrthoPediatrics(KIDS) - 2020 Q2 - Quarterly Report
2020-08-06 17:43
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) As of August 4, 2020, the reg ...
OrthoPediatrics(KIDS) - 2020 Q1 - Earnings Call Transcript
2020-05-10 16:10
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2020 Earnings Conference Call May 6, 2020 8:00 AM ET Company Participants Tram Bui - Investor Relations Mark Throdahl - President and Chief Executive Officer Fred Hite - Chief Financial Officer David Bailey - Executive Vice President Conference Call Participants Rick Wise - Stifel Matthew O’Brien - Piper Sandler Ryan Zimmerman - BTIG Kaila Krum - SunTrust Mike Matson - Needham & Company Dave Turkaly - JMP Securities Operator Ladies and gentlemen, thank you for standing ...
OrthoPediatrics(KIDS) - 2020 Q1 - Quarterly Report
2020-05-06 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (Mark One) | Title of Each Class | Trad ...
OrthoPediatrics(KIDS) - 2019 Q4 - Annual Report
2020-03-05 21:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-38242 ORTHOPEDIATRICS CORP. (Exact name of registrant as specified in its charter) Delaware 26-1761833 (State or other ...
OrthoPediatrics(KIDS) - 2019 Q4 - Earnings Call Transcript
2020-03-05 18:16
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2019 Results Earnings Conference Call March 5, 2020 8:00 AM ET Company Participants Tram Bui - Investor Relations, The Ruth Group Mark Throdahl - President and Chief Executive Officer Fred Hite - Chief Financial Officer David Bailey - Executive Vice President Conference Call Participants Rick Wise - Stifel Nicolaus Drew Stafford - Piper Jaffray Ryan Zimmerman - BTIG David Saxon - Needham & Company Daniel Stauder - JMP Securities Kaila Krum - SunTrust Robinson Humphrey ...
OrthoPediatrics(KIDS) - 2019 Q3 - Quarterly Report
2019-11-08 19:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdic ...
OrthoPediatrics(KIDS) - 2019 Q3 - Earnings Call Transcript
2019-11-08 17:33
OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2019 Results Earnings Conference Call November 8, 2019 8:00 AM ET Company Participants Tram Bui - The Ruth Group Mark Throdahl - President, Chief Executive Officer Fred Hite - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Jaffray Ryan Zimmerman - BTIG Rick Wise - Stifel David Turkaly - JMP Securities Anna Nussbaum - William Blair Mike Matson - Needham & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Or ...